Valuation: ChronoScale Holdings Corporation

Market Cap 2.64B 2.31B 2.13B 1.96B 3.7B 254B 3.78B 25.45B 10.01B 125B 9.92B 9.7B 429B P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.86B 2.5B 2.3B 2.12B 4B 275B 4.09B 27.55B 10.84B 135B 10.73B 10.5B 464B EV / Sales 2024 *
-
EV / Sales 2025 2.71x
Free-Float
2.43%
Yield 2024 *
-
Yield 2025 -
1 day+2.80%
1 week+26.46%
Current month+18.95%
1 month+13.29%
3 months+144.50%
6 months+198.31%
Current year+205.90%
1 week 19.62
Extreme 19.62
30
1 month 15.74
Extreme 15.74
30
Current year 6.93
Extreme 6.93
30
1 year 2.91
Extreme 2.9078
30
3 years 2.73
Extreme 2.73
46.93
5 years 2.73
Extreme 2.73
81.15
10 years 2.73
Extreme 2.73
1,473.75
Date Insider Type Main position Quantity % Market Cap.
13/7/26 Free

Chief Executive Officer

2,800,000 1.9568%
29/6/26 Free

Director

200,000 0.1398%
14/5/26 Free

Director

200,000 2.8063%
Change 5-day change 1-year change 3-year change Capi.($)
+2.80%+26.46%+595.53%+29.56% 3.8B
-1.97%+1.03%+28.39%-0.57% 198B
-0.58%+2.40%+7.25%-16.42% 144B
-14.15%-15.08%-33.40%-1.22% 122B
-1.32%-1.65%-57.52%-15.88% 65.44B
-2.40%-7.03%+12.08%-6.43% 49.36B
-0.11%+1.53%-23.83%-31.33% 44.74B
-3.41%-2.11%+15.33%+6.81% 37.13B
-2.44%-1.98%+28.33%+31.74% 36.23B
-1.86%-2.39%-22.85%-8.74% 28.7B
Average -2.54%+0.88%+54.93%-1.25% 72.99B
Weighted average by Cap. -3.66%-2.43%+2.12%-5.65%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Logo ChronoScale Holdings Corporation
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.
Employees
-
Date Price Change Volume
17/07/26 USD 26.43 +2.80% 365,731
16/07/26 USD 25.71 -13.23% 707,953
15/07/26 USD 29.63 +28.77% 878,288
14/07/26 USD 23.01 +16.68% 331,775
13/07/26 USD 19.72 -5.65% 104,920
  1. Stock Market
  2. Stocks
  3. CHRN Stock